Patholem
ActiveSummary
Patholem has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €138,624 and a net result of €222,666. Equity is growing by ~27.8% per year across the filed fiscal years. Its solvency ranks better than 18% of 2356 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+4
Solvency42▼-33
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9,000 at 30 days acceptable
Liquidity short (current ratio 0.52 against 0.96 in 2024; short-term debt: 76.6% and cash: 29.8% of total assets), and 82.7% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
17.3%
Return on assets
27.7%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 2356 sector peers (2025).
NBB · sector comparisonPosition among 2356 sector peers
Solvency
better than 18%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-05-2026, 80 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
80 d early
2024
28 d early
2023
7 d early
2022
18 d early
2021
24 d early
2020
24 d early
2019
30 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 30 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€138,624▼ 60.2%
2024 · €348,624
Total assets
€803,395▲ 16.2%
2024 · €691,425
Net result
€222,666▲ 47.1%
2024 · €151,399
Working capital
-€298,028▼ 3,368%
2024 · -€8,594
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€97,738▲ 2.3%€130,542▲ 33.6%€226,846▲ 73.8%€206,981▼ 8.8%€236,551▲ 14.3%
Net result€70,956within the sector's middle half▼ 6.0%€87,742within the sector's middle half▲ 23.7%€165,066within the sector's middle half▲ 88.1%€151,399within the sector's middle half▼ 8.3%€222,666within the sector's middle half▲ 47.1%
Equity€169,956within the sector's middle half▼ 2.3%€147,698within the sector's middle half▼ 13.1%€311,931within the sector's middle half▲ 111%€348,624within the sector's middle half▲ 11.8%€138,624within the sector's middle half▼ 60.2%
Total assets€268,759below the sector's middle half▲ 45.1%€680,881within the sector's middle half▲ 153%€669,811within the sector's middle half▼ 1.6%€691,425within the sector's middle half▲ 3.2%€803,395within the sector's middle half▲ 16.2%
Debt€98,803▲ 785%€533,183▲ 440%€357,881▼ 32.9%€342,801▼ 4.2%€664,771▲ 93.9%
Working capital€169,032▼ 2.9%-€62,075€29,155-€8,594-€298,028▼ 3,368%
Solvency63.2%within the sector's middle half▼ 30.7pp21.7%below the sector's middle half▼ 41.5pp46.6%within the sector's middle half▲ 24.9pp50.4%within the sector's middle half▲ 3.9pp17.3%below the sector's middle half▼ 33.2pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 14% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €803,395
Fixed assets
€486,030 ▲ 0.6%
Current assets
€317,365 ▲ 52.5%
Equity and liabilities €803,395
Equity
€138,624 ▼ 60.2%
Debt
€664,771 ▲ 93.9%
Debt's share of the balance-sheet total rises from 49.6% to 82.7%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€236,704▲
2024 · €207,150
Cash flow
€222,820▲
2024 · €151,568
Current ratio
0.52▼
2024 · 0.96
Debt to equity
4.80▲
2024 · 0.98
ROE
160.6%▲
2024 · 43.4%
ROA
27.7%▲
2024 · 21.9%
Interest coverage
32.06▲
2024 · 22.65
Debt ≤ 1 year
€615,393▲
2024 · €216,685
Debt > 1 year
€44,334▼
2024 · €120,333
Income taxes
€60,100▲
2024 · €50,522
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €446 | €378 | €378 | €170 | €154 | ▼ 9.5% |
| Other operating charges640/8 | €1,434 | €1,290 | €1,599 | €1,289 | €3,277 | ▲ 154% |
| Gross operating margin9900 | €99,618 | €132,209 | €228,822 | €208,439 | €239,981 | ▲ 15.1% |
| Operating profit (loss)9901 | €97,738 | €130,542 | €226,846 | €206,981 | €236,551 | ▲ 14.3% |
| Financial income75/76B | €15 | €339 | €1,933 | €4,087 | €53,599 | ▲ 1,212% |
| Recurring financial income75 | €15 | €339 | €1,933 | €4,087 | €53,599 | ▲ 1,212% |
| Financial charges65/66B | €96 | €4,852 | €8,130 | €9,147 | €7,383 | ▼ 19.3% |
| Recurring financial charges65 | €96 | €4,852 | €8,130 | €9,147 | €7,383 | ▼ 19.3% |
| Profit (loss) for the period before taxes9903 | €97,657 | €126,029 | €220,649 | €201,921 | €282,766 | ▲ 40.0% |
| Income taxes67/77 | €26,702 | €38,288 | €55,584 | €50,522 | €60,100 | ▲ 19.0% |
| Profit (loss) for the period9904 | €70,956 | €87,742 | €165,066 | €151,399 | €222,666 | ▲ 47.1% |
| Profit (loss) for the period to be appropriated9905 | €70,956 | €87,742 | €165,066 | €151,399 | €222,666 | ▲ 47.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €268,759 | €680,881 | €669,811 | €691,425 | €803,395 | ▲ 16.2% |
| Fixed assets21/28 | €925 | €483,881 | €483,503 | €483,333 | €486,030 | ▲ 0.6% |
| Tangible fixed assets22/27 | €925 | €547 | €170 | - | €2,696 | - |
| Plant, machinery and equipment23 | - | - | - | - | €2,696 | - |
| Furniture and vehicles24 | €925 | €547 | €170 | - | - | - |
| Financial fixed assets28 | - | €483,333 | €483,333 | €483,333 | €483,333 | = |
| Current assets29/58 | €267,834 | €197,000 | €186,308 | €208,091 | €317,365 | ▲ 52.5% |
| Amounts receivable within one year40/41 | €20,299 | €9,793 | €4,429 | €14,533 | €10,104 | ▼ 30.5% |
| Other amounts receivable41 | €20,299 | €9,793 | €4,429 | €14,533 | €10,104 | ▼ 30.5% |
| Current investments50/53 | - | €11,881 | €35,644 | €43,564 | €43,564 | = |
| Cash at bank and in hand54/58 | €247,536 | €136,256 | €107,848 | €122,620 | €239,759 | ▲ 95.5% |
| Deferred charges and accrued income490/1 | - | €39,070 | €38,388 | €27,374 | €23,938 | ▼ 12.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €268,759 | €680,881 | €669,811 | €691,425 | €803,395 | ▲ 16.2% |
| Equity10/15 | €169,956 | €147,698 | €311,931 | €348,624 | €138,624 | ▼ 60.2% |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €151,356 | €121,860 | €121,860 | €330,024 | €120,024 | ▼ 63.6% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | - | - | - | - |
| Reserves not available under the articles1311 | €1,860 | €1,860 | - | - | - | - |
| Distributable reserves133 | €149,496 | €120,000 | €121,860 | €330,024 | €120,024 | ▼ 63.6% |
| Profit (loss) carried forward14 | - | €7,238 | €171,471 | - | - | - |
| Amounts payable17/49 | €98,803 | €533,183 | €357,881 | €342,801 | €664,771 | ▲ 93.9% |
| Amounts payable after more than one year17 | - | €266,000 | €196,333 | €120,333 | €44,334 | ▼ 63.2% |
| Financial debts170/4 | - | €266,000 | €196,333 | €120,333 | €44,334 | ▼ 63.2% |
| Amounts payable within one year42/48 | €98,803 | €259,075 | €157,153 | €216,685 | €615,393 | ▲ 184% |
| Current portion of amounts payable after more than one year42 | - | €76,000 | €76,000 | €76,000 | €76,000 | = |
| Trade debts44 | €7,928 | €2,188 | €237 | €3,116 | €2,517 | ▼ 19.2% |
| Suppliers440/4 | €7,928 | €2,188 | €237 | €3,116 | €2,517 | ▼ 19.2% |
| Taxes, remuneration and social security45 | €8,920 | €8,338 | €6,338 | €2,400 | €32,170 | ▲ 1,240% |
| Taxes450/3 | €8,920 | €8,338 | €6,338 | €2,400 | €32,170 | ▲ 1,240% |
| Other amounts payable47/48 | €81,954 | €172,550 | €74,579 | €135,169 | €504,706 | ▲ 273% |
| Accrued charges and deferred income492/3 | - | €8,107 | €4,394 | €5,783 | €5,045 | ▼ 12.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €70,956 | €87,742 | €165,066 | €151,399 | €222,666 | ▲ 47.1% |
| + Depreciation and write-downs630 | €446 | €378 | €378 | €170 | €154 | ▼ 9.5% |
| Operating cash flow (approximation) | €71,401 | €88,119 | €165,443 | €151,568 | €222,820 | ▲ 47.0% |
| Investment in fixed assets (approximation) | - | -€483,333 | €0 | €0 | -€2,850 | - |
| Change in cash | - | -€111,280 | -€28,408 | €14,772 | €117,138 | ▲ 693% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-05
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €222,666 ▲47.1%
Operating result €236,551, net result €222,666, both a record.
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
24-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Equity above €200,000Eq €311,931 ▲111%
6 profitable years in a row build equity to €311,931.
13-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
07-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
07-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Equity above €150,000Eq €174,001 ▲75.2%
3 profitable years in a row build equity to €174,001.
01-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Liquidity quadruplescurrent ratio 17.65
Current ratio from 3.96 to 17.65; short-term debt falls from €7,688 to €5,966.
04-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kortrijk · 1 establishment unit since 2018
Ground area
3,588 m²
Building footprint
429 m²
Volume, LiDAR
2,067 m³
2 parcels, Flanders · tallest building 11.0 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Patholem
since 20182.281.107.428
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34022E0421/00N006 | Flanders | 3,444 m² | 1 · 364 m² | 9.6 m · 1 fl. |
| 34353B0164/00W002 | Flanders | 143 m² | 1 · 65 m² | 10.9 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 1
-
33.33%
According to the 2025 annual accounts of Patholem and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
Dr. Anne-Sophie Vliegen - Radioloog
BE 0568.524.819
Hasselt · Eq €138,600
DOKTER DE VUYST CARDIOLOOG
BE 0649.618.601
Pajottegem · Eq €138,590
Dr. Kathleen Dieryck
BE 0821.096.981
Hasselt · Eq €138,563
Dokter Christophe De Block
BE 0628.960.470
Brasschaat · Eq €138,560
Docteur Félicie LORTHIOIR
BE 0802.741.316
Liège · Eq €138,703
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 6,685 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded27-09-2018
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
72109Other research and development on natural sciences
E-invoicing
Reachable via Peppol
Peppol ID
0208:0705937888
Also
9925:BE0705937888
Registered
24-03-2026
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.